The News
Waiv, a Paris-based startup emerging from Owkin, has raised $33 million to advance AI-enabled precision oncology testing. This funding aims to accelerate the development and deployment of innovative testing solutions in the oncology sector.
Why It Matters
The infusion of capital into Waiv highlights the growing intersection of AI and healthcare, particularly in precision medicine. This development could enhance the capabilities of AI systems in diagnosing and treating cancer, potentially leading to improved patient outcomes and a shift in how oncological care is delivered.
Key Evidence
The information is sourced from a reliable news outlet, finanznachrichten, reporting on Waiv's funding announcement.
Original Article
finanznachrichten
DE source 路 Published 3d ago
https://www.finanznachrichten.de/nachrichten-2026-03/67927619-waiv-secures-dollar-33-million-to-scale-ai-precision-testing-004.htm